Review
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 21, 2017; 23(23): 4146-4157
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4146
Antioxidant dietary approach in treatment of fatty liver: New insights and updates
Alessandra Ferramosca, Mariangela Di Giacomo, Vincenzo Zara
Alessandra Ferramosca, Mariangela Di Giacomo, Vincenzo Zara, Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Via Provinciale Lecce-Monteroni, I-73100 Lecce, Italy
Author contributions: Ferramosca A designed the review and wrote the article; Di Giacomo M wrote the article; Zara V designed the review, wrote the article and made critical revisions.
Conflict-of-interest statement: The authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Alessandra Ferramosca, Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Via Provinciale Lecce-Monteroni, I-73100 Lecce, Italy. alessandra.ferramosca@unisalento.it
Telephone: +39-0832-298698 Fax: +39-0832-298626
Received: January 20, 2017
Peer-review started: January 22, 2017
First decision: February 9, 2017
Revised: February 22, 2017
Accepted: June 1, 2017
Article in press: June 1, 2017
Published online: June 21, 2017
Processing time: 150 Days and 13.7 Hours
Core Tip

Core tip: So far, there are no approved drugs for the treatment or the prevention of fatty liver and strategies mainly rely on dietary, physical activity and lifestyle modifications, as well as correction of hepatic steatosis-associated metabolic disturbances. This review mainly covers the biochemical mechanisms responsible for the dysfunctions in mitochondrial bioenergetics observed in fatty liver and analyses the most recent data evidencing the effects of new bioactive compounds on the preservation of mitochondrial function. New insight into biochemical details underlying fat accumulation in the liver could lead to more targeted and effective therapeutics for fatty liver.